# AdvanSix Inc.: overview

ASIX · NYSE · CIK 1673985 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/asix.md) · [Financials](/companies/asix/financials.md) · [Filings](/companies/asix/filings.md) · [Insiders](/companies/asix/insiders.md)

Latest reported revenue: [$421.3m](/filings/0001673985-26-000049.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001673985-26-000049).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [398](/filings/0001673985-25-000135.md) | [329 d](/filings/0001673985-26-000008.md) | [378](/filings/0001673985-26-000037.md) | [410](/filings/0001673985-26-000049.md) | [374](/filings/0001673985-25-000135.md) | [360 d](/filings/0001673985-26-000008.md) | [404](/filings/0001673985-26-000037.md) | [421](/filings/0001673985-26-000049.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [5.6%](/filings/0001673985-25-000135.md) | [0.1% d](/filings/0001673985-26-000008.md) | [6.2%](/filings/0001673985-26-000049.md) | [7.7%](/filings/0001673985-26-000049.md) | [(0.7%)](/filings/0001673985-25-000135.md) | [(0.8%) d](/filings/0001673985-26-000008.md) | [(3.8%)](/filings/0001673985-26-000049.md) | [0.8%](/filings/0001673985-26-000049.md) |
| Diluted EPS | $ per share | [0.82](/filings/0001673985-25-000135.md) | not reported | [0.86](/filings/0001673985-26-000037.md) | [1.15](/filings/0001673985-26-000049.md) | [(0.10)](/filings/0001673985-25-000135.md) | not reported | [(0.58)](/filings/0001673985-26-000037.md) | [0.12](/filings/0001673985-26-000049.md) |
| Free cash flow | $m | [26.8 d](/filings/0001673985-25-000135.md) | [29.8 d](/filings/0001673985-26-000008.md) | [(22.6)](/filings/0001673985-26-000037.md) | [(7.2) d](/filings/0001673985-26-000049.md) | [0.1 d](/filings/0001673985-25-000135.md) | [36.1 d](/filings/0001673985-26-000008.md) | [(51.3)](/filings/0001673985-26-000037.md) | [(10.7) d](/filings/0001673985-26-000049.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,685](/filings/0001673985-22-000010.md) | [1,946](/filings/0001673985-25-000011.md) | [1,534](/filings/0001673985-26-000008.md) | [1,518](/filings/0001673985-26-000008.md) | [1,522](/filings/0001673985-26-000008.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [8.3%](/filings/0001673985-24-000014.md) | [8.8%](/filings/0001673985-25-000011.md) | [3.6%](/filings/0001673985-26-000008.md) | [2.9%](/filings/0001673985-26-000008.md) | [3.2%](/filings/0001673985-26-000008.md) |
| Diluted EPS | $ per share | [4.81](/filings/0001673985-24-000014.md) | [5.92](/filings/0001673985-25-000011.md) | [1.95](/filings/0001673985-26-000008.md) | [1.62](/filings/0001673985-26-000008.md) | [1.80](/filings/0001673985-26-000008.md) |
| Free cash flow | $m | [162](/filings/0001673985-24-000014.md) | [184](/filings/0001673985-25-000011.md) | [10.2](/filings/0001673985-26-000008.md) | [1.7](/filings/0001673985-26-000008.md) | [6.4](/filings/0001673985-26-000008.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/asix/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $48.5m | 2,440,480 |  | Added +156,545 |
| [CastleKnight Management LP](/funds/1835751.md) | 2026-06-30 | $31.6m | 1,590,318 |  | Added +958,537 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $28.0m | 1,407,349 |  | Added +96,343 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $27.1m | 1,363,346 |  | Added +236,709 |
| [AEGIS FINANCIAL CORP](/funds/1140753.md) | 2026-06-30 | $24.0m | 1,209,629 |  | Unchanged |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $22.9m | 1,151,355 |  | Added +27,898 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $21.1m | 863,897 |  | Reduced −7,079 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $13.9m | 700,057 |  | Added +61,486 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $13.8m | 692,516 |  | Added +40,268 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $13.2m | 664,944 |  | Reduced −63,348 |

## Recent filings

[All 699 filings](/companies/asix/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-17 | 20:20 ET | [8-K](/filings/0000950157-26-000916.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950157-26-000916 |
| 2026-08-07 | 20:03 ET | [10-Q](/filings/0001673985-26-000049.md) | Quarterly report, period 2026-06-30 | 0001673985-26-000049 |
| 2026-08-07 | 10:29 ET | [8-K](/filings/0001673985-26-000045.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001673985-26-000045 |
| 2026-06-23 | 20:28 ET | [8-K](/filings/0001673985-26-000040.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001673985-26-000040 |
| 2026-05-08 | 20:04 ET | [10-Q](/filings/0001673985-26-000037.md) | Quarterly report, period 2026-03-31 | 0001673985-26-000037 |
| 2026-05-08 | 10:30 ET | [8-K](/filings/0001673985-26-000033.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001673985-26-000033 |
| 2026-04-29 | 20:11 ET | [DEF 14A](/filings/0001673985-26-000022.md) | Proxy statement, period 2026-06-22 | 0001673985-26-000022 |
| 2026-04-13 | 10:49 ET | [8-K](/filings/0001673985-26-000012.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001673985-26-000012 |
| 2026-02-20 | 21:17 ET | [10-K](/filings/0001673985-26-000008.md) | Annual report, period 2025-12-31 | 0001673985-26-000008 |
| 2026-02-20 | 11:30 ET | [8-K](/filings/0001673985-26-000004.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001673985-26-000004 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001673985-26-000008.md), filed Feb 20, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/1852465a-910b-444b-a66a-6a1de79863e6)

## About the filer

- CIK: 1673985
- Tickers: ASIX
- Exchange: NYSE
- SIC code: 2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.